Subtype of atrial fibrillation and the outcome of transcatheter aortic valve replacement: The FinnValve Study

Näytä kaikki kuvailutiedot



Pysyväisosoite

http://hdl.handle.net/10138/319504

Lähdeviite

Jaakkola , J , Jaakkola , S , Airaksinen , K E J , Husso , A , Juvonen , T , Laine , M , Virtanen , M , Maaranen , P , Niemelä , M , Mäkikallio , T , Savontaus , M , Tauriainen , T , Valtola , A , Vento , A , Eskola , M , Raivio , P & Biancari , F 2020 , ' Subtype of atrial fibrillation and the outcome of transcatheter aortic valve replacement: The FinnValve Study ' , PLoS One , vol. 15 , no. 9 , 0238953 . https://doi.org/10.1371/journal.pone.0238953

Julkaisun nimi: Subtype of atrial fibrillation and the outcome of transcatheter aortic valve replacement: The FinnValve Study
Tekijä: Jaakkola, Jussi; Jaakkola, Samuli; Airaksinen, K. E. Juhani; Husso, Annastiina; Juvonen, Tatu; Laine, Mika; Virtanen, Marko; Maaranen, Pasi; Niemelä, Matti; Mäkikallio, Timo; Savontaus, Mikko; Tauriainen, Tuomas; Valtola, Antti; Vento, Antti; Eskola, Markku; Raivio, Peter; Biancari, Fausto
Tekijän organisaatio: HUS Heart and Lung Center
III kirurgian klinikka
Clinicum
Department of Surgery
Kardiologian yksikkö
Helsinki University Hospital Area
Päiväys: 2020-09-11
Kieli: eng
Sivumäärä: 12
Kuuluu julkaisusarjaan: PLoS One
ISSN: 1932-6203
DOI-tunniste: https://doi.org/10.1371/journal.pone.0238953
URI: http://hdl.handle.net/10138/319504
Tiivistelmä: Whether the subtype of atrial fibrillation affects outcomes after transcatheter aortic valve replacement for aortic stenosis is unclear. The nationwide FinnValve registry included 2130 patients who underwent primary after transcatheter aortic valve replacement for aortic stenosis during 2008–2017. Altogether, 281 (13.2%) patients had pre-existing paroxysmal atrial fibrillation, 651 (30.6%) had pre-existing non-paroxysmal atrial fibrillation and 160 (7.5%) were diagnosed with new-onset atrial fibrillation during the index hospitalization. The median follow-up was 2.4 (interquartile range: 1.6–3.8) years. Paroxysmal atrial fibrillation did not affect 30-day or overall mortality (p-values >0.05). Non-paroxysmal atrial fibrillation demonstrated an increased risk of overall mortality (hazard ratio: 1.61, 95% confidence interval: 1.35–1.92; p0.05). In conclusion, non-paroxysmal atrial fibrillation and new-onset atrial fibrillation are associated with increased mortality after transcatheter aortic valve replacement for aortic stenosis, whereas paroxysmal atrial fibrillation has no effect on mortality. These findings suggest that non-paroxysmal atrial fibrillation rather than paroxysmal atrial fibrillation may be associated with structural cardiac damage which is of prognostic significance in patients with aortic stenosis undergoing transcatheter aortic valve replacement.
Avainsanat: 3126 Surgery, anesthesiology, intensive care, radiology
CLINICAL-OUTCOMES
INCREASED MORTALITY
IMPLANTATION
IMPACT
STENOSIS
MANAGEMENT
RISK
Vertaisarvioitu: Kyllä
Tekijänoikeustiedot: cc_by
Pääsyrajoitteet: openAccess
Rinnakkaistallennettu versio: publishedVersion


Tiedostot

Latausmäärä yhteensä: Ladataan...

Tiedosto(t) Koko Formaatti Näytä
journal.pone.0238953.pdf 508.3KB PDF Avaa tiedosto

Viite kuuluu kokoelmiin:

Näytä kaikki kuvailutiedot